Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study

Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined the association between hypothyroidism and dyslipidemia in patients undergoing bexarotene therapy. The aim of this study is...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Katsunori Manaka, Junichiro Sato, Yusuke Hikima, Hirofumi Horikoshi, Maho Taguchi, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Reiko Yamashita, Makoto Sugaya, Toshihisa Hamada, Masaomi Nangaku, Taroh Iiri, Noriko Makita
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	The Japan Endocrine Society 2024-08-01
سلاسل:	Endocrine Journal
الموضوعات:	bexarotene hypothyroidism dyslipidemia hypertriglyceridemia
الوصول للمادة أونلاين:	https://www.jstage.jst.go.jp/article/endocrj/71/8/71_EJ23-0699/_html/-char/en
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!